Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial
published in: International journal of endocrinology
date of publication: 2015-07-29
main subject: phase II clinical trial, thyroid carcinoma
Cites articles 26
- 2008-12-01
- 2003-08-01
Date
Title
Article - wd:Q35941777